{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:39:37Z","timestamp":1780760377990,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Associazione Malattie Metaboliche Congenite, Italy","award":["MORRONEAMMEC18"],"award-info":[{"award-number":["MORRONEAMMEC18"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ymgme.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T01:07:14Z","timestamp":1572743234000},"page":"47-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: An overview"],"prefix":"10.1016","volume":"129","author":[{"given":"Anna","family":"Caciotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Melani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Cellai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Catarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Chilleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Mavridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Michelakakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Fioravanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"d\u2019Azzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Morrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2019.09.005_bb0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/sj.jp.7211335","article-title":"Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase","volume":"25","author":"Loren","year":"2005","journal-title":"J. Perinatol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0010","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1038\/ncomms3734","article-title":"Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-beta secretion via deregulated lysosomal exocytosis","volume":"4","author":"Annunziata","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1524-475X.2009.00525.x","article-title":"Role of the elastin receptor complex (S-Gal\/Cath-A\/Neu-1) in skin repair and regeneration","volume":"17","author":"Antonicelli","year":"2009","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0020","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.devcel.2008.05.005","article-title":"Neuraminidase 1 is a negative regulator of lysosomal exocytosis","volume":"15","author":"Yogalingam","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0025","doi-asserted-by":"crossref","first-page":"28430","DOI":"10.1074\/jbc.M109.031419","article-title":"Heterodimerization of the sialidase NEU1 with the chaperone protective protein\/cathepsin A prevents its premature oligomerization","volume":"284","author":"Bonten","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205871","article-title":"Sialidosis type I: ophthalmological findings","volume":"2014","author":"Sobral","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/21678707.2015.1025746","article-title":"Pathogenesis, emerging therapeutic targets and treatment in sialidosis expert","volume":"3","author":"d'Azzo","year":"2015","journal-title":"Opin Orphan Drugs"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0040","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jnnp.43.10.934","article-title":"Cherry-red spot myoclonus syndrome and alpha-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult","volume":"43","author":"Franceschetti","year":"1980","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0045","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1101\/gad.10.24.3156","article-title":"Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis","volume":"10","author":"Bonten","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0050","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1074\/jbc.272.7.4549","article-title":"Identification of a sialidase encoded in the human major histocompatibility complex","volume":"272","author":"Milner","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0055","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/humu.10268","article-title":"Molecular pathology of NEU1 gene in sialidosis","volume":"22","author":"Seyrantepe","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12098-016-2286-9","article-title":"Sialidosis type 1 with a novel mutation in the neuraminidase-1 (NEU1) gene","volume":"84","author":"Gowda","year":"2017","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jocn.2016.02.015","article-title":"Optical coherence tomography findings in a patient with type 1 sialidosis","volume":"31","author":"Kersten","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0070","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jocn.2012.12.014","article-title":"Variable phenotype and severity of sialidosis expressed in two siblings presenting with ataxia and macular cherry-red spots","volume":"20","author":"de Rezende Pinto","year":"2013","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1756285610395653","article-title":"Myoclonic disorders: a practical approach for diagnosis and treatment","volume":"4","author":"Kojovic","year":"2011","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0080","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/B978-0-444-52891-9.00069-5","article-title":"Myoclonus and epilepsy","volume":"111","author":"Guerrini","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0085","first-page":"266","article-title":"Sialidosis type I: pathological study in an adult","volume":"8","author":"Allegranza","year":"1989","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0090","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1212\/WNL.0000000000005209","article-title":"Child neurology: type 1 sialidosis due to a novel mutation in NEU1 gene","volume":"90","author":"Aravindhan","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0303-8467(91)90050-Y","article-title":"Sialidosis type I: first report in the Indian population. A clinical, biochemical and electrophysiological study","volume":"93","author":"Bhigjee","year":"1991","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0100","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1093\/hmg\/9.18.2715","article-title":"Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis","volume":"9","author":"Bonten","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0105","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.0000000000000482","article-title":"Expanding sialidosis spectrum by genome-wide screening: NEU1 mutations in adult-onset myoclonus","volume":"82","author":"Canafoglia","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2006.03.013","article-title":"First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study","volume":"247","author":"Chen","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0115","first-page":"391","article-title":"Sialidosis (mucolipidosis I)","volume":"32","author":"Durand","year":"1977","journal-title":"Helv. Paediatr. Acta"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1528-1157.1977.tb05589.x","article-title":"Electrophysiological studies in two patients with cherry red spot\u2013myoclonus syndrome","volume":"18","author":"Engel","year":"1977","journal-title":"Epilepsia"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00282535","article-title":"Normomorphic sialidosis in two female adults with severe neurologic disease and without sialyl oligosacchariduria","volume":"74","author":"Harzer","year":"1986","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archophthalmol.2007.31","article-title":"Cherry red spot in sialidosis (mucolipidosis type I)","volume":"126","author":"Heroman","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10038-002-8652-7","article-title":"Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes","volume":"47","author":"Itoh","year":"2002","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01799994","article-title":"Cherry-red spot\u2013myoclonus syndrome in a Japanese family","volume":"5","author":"Kitagawa","year":"1982","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0145","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1468-1331.2009.02622.x","article-title":"A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry-red spot myoclonus syndrome","volume":"16","author":"Lai","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00735411","article-title":"Sialidosis type I: first report in the Czech population of two siblings with cherry-red spot myoclonus syndrome but without sialyloligosacchariduria","volume":"17","author":"Ledvinova","year":"1994","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000117119","article-title":"Multimodality evoked potentials and EEG in a case of cherry red spot-myoclonus syndrome and alpha-neuraminidase deficiency (sialidosis type 1)","volume":"35","author":"Louboutin","year":"1995","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0160","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/9.7.1075","article-title":"Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex","volume":"9","author":"Lukong","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0165","first-page":"30","article-title":"A new observation of cherry-red spot myoclonus syndrome (author's transl)","volume":"80","author":"Martin","year":"1980","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00869770","article-title":"Action myoclonus induced by visually guided movement","volume":"241","author":"Mitoma","year":"1993","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0175","first-page":"1","article-title":"Multigene panel next generation sequencing in a patient with cherry red macular spot: Identification of two novel mutations in NEU1 gene causing sialidosis type I associated with mild to unspecific biochemical and enzymatic findings","volume":"10","author":"Mutze","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s100380070034","article-title":"Molecular and structural studies of Japanese patients with sialidosis type 1","volume":"45","author":"Naganawa","year":"2000","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0185","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/0006-291X(77)91124-X","article-title":"Neuraminidase deficiency in the cherry red spot-myoclonus syndrome","volume":"79","author":"O'Brien","year":"1977","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000008141","article-title":"Type I sialidosis: a clinical, biochemical and neuroradiological study","volume":"43","author":"Palmeri","year":"2000","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0195","first-page":"1048","article-title":"Novel mutations in the neuraminidase-1 (NEU1) gene in two patients of sialidosis in India Indian","volume":"136","author":"Ranganath","year":"2012","journal-title":"J. Med. Res."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0200","first-page":"9","article-title":"Pitfalls in diagnosing neuraminidase deficiency: psychosomatics and normal sialic acid excretion","volume":"25","author":"Schene","year":"2016","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2169\/internalmedicine.52.8901","article-title":"Clinical and serial MRI findings of a sialidosis type I patient with a novel missense mutation in the NEU1 gene","volume":"52","author":"Sekijima","year":"2013","journal-title":"Intern. Med."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1469-1809.1979.tb01546.x","article-title":"Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobility of some enzymes known to be glycoproteins. II. Enzymes studies","volume":"43","author":"Swallow","year":"1979","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1399-0004.1978.tb01194.x","article-title":"Sialidase (alpha-n-acetyl neuraminidase) deficiency: the enzyme defect in an adult with macular cherry-red spots and myoclonus without dementia","volume":"13","author":"Thomas","year":"1978","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0220","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp.42.10.873","article-title":"Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobilities of some enzymes known to be glycoproteins. 1. Clinical findings","volume":"42","author":"Thomas","year":"1979","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0225","first-page":"40","article-title":"Sialidosis (neuraminidase deficiency) types I and II: neuro-ophthalmic manifestations","volume":"7","author":"Till","year":"1987","journal-title":"J. Clin. Neuroophthalmol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF01799483","article-title":"Biochemical study of sialidosis type I in a Russian family","volume":"10","author":"Tsvetkova","year":"1987","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0235","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00401-009-0544-x","article-title":"Sialidosis type I carrying V217M\/G243R mutations in lysosomal sialidase: an autopsy study demonstrating terminal sialic acid in lysosomal lamellar inclusions and cerebellar dysplasia","volume":"119","author":"Uchihara","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbagen.2009.01.006","article-title":"Protective protein\/cathepsin A rescues N-glycosylation defects in neuraminidase-1","volume":"1790","author":"Wang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0245","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10072-010-0392-4","article-title":"Sialidosis type I with neoplasms in siblings: the first clinical cases","volume":"32","author":"Yagi","year":"2011","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0022-510X(95)00102-8","article-title":"Activated sialidase activity in transformed lymphocytes by Epstein-Barr (EB) virus of sialidosis type I (cherry-red spot-myoclonus syndrome)","volume":"131","author":"Yamamoto","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12886-016-0201-9","article-title":"Fundus autofluorescence and optical coherence tomography of a macular cherry-red spot in a case report of sialidosis","volume":"16","author":"Zou","year":"2016","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0260","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ana.410070510","article-title":"Peripheral neuropathy in the cherry-red spot-myoclonus syndrome (sialidosis type I)","volume":"7","author":"Steinman","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0265","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbadis.2011.03.018","article-title":"GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings","volume":"1812","author":"Caciotti","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1684\/epd.2016.0845","article-title":"Sialidoses","volume":"18","author":"Franceschetti","year":"2016","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0275","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1474-4422(05)70043-0","article-title":"Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects","volume":"4","author":"Shahwan","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0280","doi-asserted-by":"crossref","first-page":"26898","DOI":"10.1074\/jbc.M113.464503","article-title":"Basal autophagy is required for the efficient catabolism of sialyloligosaccharides","volume":"288","author":"Seino","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0285","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1042\/EBC20170055","article-title":"Dysregulation of autophagy as a common mechanism in lysosomal storage diseases","volume":"61","author":"Seranova","year":"2017","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0290","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/j.bbamcr.2009.01.016","article-title":"The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases","volume":"1793","author":"Yue","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2019.09.005_bb0295","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eplepsyres.2011.01.013","article-title":"Characterization of severe action myoclonus in sialidoses","volume":"94","author":"Canafoglia","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ymgme.2019.09.005_bb0300","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.2174\/1381612823666170809114654","article-title":"Update on pharmacological treatment of progressive myoclonus epilepsies","volume":"23","author":"Ferlazzo","year":"2017","journal-title":"Curr. Pharm. Des."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219305372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219305372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:42Z","timestamp":1761089142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219305372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1096719219305372"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.09.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type I sialidosis, a normosomatic lysosomal disease, in the differential diagnosis of late-onset ataxia and myoclonus: An overview","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}